US Autoimmune Disease Diagnostics Market

ID: MRFR/LS/14149-HCR
100 Pages
Satyendra Maurya
Last Updated: April 06, 2026
US Autoimmune Disease Diagnostics Market Research Report: Size, Share, Trend Analysis By Test Type (Serological Tests, Molecular Diagnostics, Imaging Tests, Biopsies), By Disease Type (Rheumatoid Arthritis, Lupus, Multiple Sclerosis, Type 1 Diabetes, Thyroid Disorders), By End Users (Hospitals, Diagnostic Laboratories, Research Institutes) and By Product Type (Reagents, Instrumentations, Software) - Growth Outlook & Industry Forecast 2025 To 2035
US Autoimmune Disease Diagnostics Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)6.72%
2024 Market Size$ 1,272.58 Million
2025 Market Size$ 1,358.1 Million
2035 Market Size$ 2,602.62 Million
Key Players
Abbott Laboratories
Roche Holding AG
Thermo Fisher Scientific Inc.
Siemens Healthineers AG
Bristol-Myers Squibb Company
Quest Diagnostics Incorporated
Trends
  • Technological Advancements in Diagnostics
  • Increased Awareness and Demand for Testing
  • Regulatory Support and Innovation
Opportunities
  • Advancements in Biomarker Discovery
  • Rising Consumer Awareness and Education
  • Growing Demand for Point-of-Care Testing
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Chemicals and Materials, BY Test Type (USD Million)
      1. 4.1.1 Serological Tests
      2. 4.1.2 Molecular Diagnostics
      3. 4.1.3 Imaging Tests
      4. 4.1.4 Biopsies
    2. 4.2 Chemicals and Materials, BY Disease Type (USD Million)
      1. 4.2.1 Rheumatoid Arthritis
      2. 4.2.2 Lupus
      3. 4.2.3 Multiple Sclerosis
      4. 4.2.4 Type 1 Diabetes
      5. 4.2.5 Thyroid Disorders
    3. 4.3 Chemicals and Materials, BY End-user (USD Million)
      1. 4.3.1 Hospitals
      2. 4.3.2 Diagnostic Laboratories
      3. 4.3.3 Research Institutes
    4. 4.4 Chemicals and Materials, BY Product Type (USD Million)
      1. 4.4.1 Reagents
      2. 4.4.2 Instrumentations
      3. 4.4.3 Software
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Abbott Laboratories (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Roche Holding AG (CH)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Thermo Fisher Scientific Inc. (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Siemens Healthineers AG (DE)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Bristol-Myers Squibb Company (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Quest Diagnostics Incorporated (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Bio-Rad Laboratories Inc. (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Genzyme Corporation (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY TEST TYPE
    3. 6.3 US MARKET ANALYSIS BY DISEASE TYPE
    4. 6.4 US MARKET ANALYSIS BY END-USER
    5. 6.5 US MARKET ANALYSIS BY PRODUCT TYPE
    6. 6.6 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF CHEMICALS AND MATERIALS
    9. 6.9 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
    11. 6.11 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
    12. 6.12 CHEMICALS AND MATERIALS, BY TEST TYPE, 2024 (% SHARE)
    13. 6.13 CHEMICALS AND MATERIALS, BY TEST TYPE, 2024 TO 2035 (USD Million)
    14. 6.14 CHEMICALS AND MATERIALS, BY DISEASE TYPE, 2024 (% SHARE)
    15. 6.15 CHEMICALS AND MATERIALS, BY DISEASE TYPE, 2024 TO 2035 (USD Million)
    16. 6.16 CHEMICALS AND MATERIALS, BY END-USER, 2024 (% SHARE)
    17. 6.17 CHEMICALS AND MATERIALS, BY END-USER, 2024 TO 2035 (USD Million)
    18. 6.18 CHEMICALS AND MATERIALS, BY PRODUCT TYPE, 2024 (% SHARE)
    19. 6.19 CHEMICALS AND MATERIALS, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TEST TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY DISEASE TYPE, 2025-2035 (USD Million)
      3. 7.2.3 BY END-USER, 2025-2035 (USD Million)
      4. 7.2.4 BY PRODUCT TYPE, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Autoimmune Disease Diagnostics Market Segmentation

US Autoimmune Disease Diagnostics Market By Test Type (USD Million, 2025-2035)

  • Serological Tests
  • Molecular Diagnostics
  • Imaging Tests
  • Biopsies

US Autoimmune Disease Diagnostics Market By Disease Type (USD Million, 2025-2035)

  • Rheumatoid Arthritis
  • Lupus
  • Multiple Sclerosis
  • Type 1 Diabetes
  • Thyroid Disorders

US Autoimmune Disease Diagnostics Market By End-user (USD Million, 2025-2035)

  • Hospitals
  • Diagnostic Laboratories
  • Research Institutes

US Autoimmune Disease Diagnostics Market By Product Type (USD Million, 2025-2035)

  • Reagents
  • Instrumentations
  • Software

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.